PMID: 11331805May 2, 2001Paper

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine

Psychiatric Services : a Journal of the American Psychiatric Association
D L KellyR R Conley

Abstract

This study compared the discharge rates and drug costs of 789 patients with schizophrenia or schizoaffective disorder who began pharmacotherapy with olanzapine or risperidone between July 1997 and June 1998. Discharge rates 30 days after the start of treatment were 45 percent for the patients treated with risperidone and 32 percent for those treated with olanzapine (p=.001). Daily drug costs during the same period were $6.42 for risperidone and $12.29 for olanzapine (p<.001). For risperidone, lower dosages were associated with higher hospital discharge rates, whereas no significant association was observed for olanzapine. These data suggest that among inpatients with schizophrenia or schizoaffective disorder, use of risperidone results in a higher discharge rate and a lower drug cost than use of olanzapine.

Citations

Oct 21, 2005·Administration and Policy in Mental Health·Michael JohnsrudAmy Grogg
Feb 20, 2003·Schizophrenia Research·Teresa J HudsonCarol R Thrush
Mar 18, 2006·Acta Psychiatrica Scandinavica. Supplementum·L KopalaR Balshaw
Jan 15, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·P Joseph GibsonJanet L Ramsey
Jan 27, 2004·The Annals of Pharmacotherapy·Gordon G LiuXuemei Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Psychiatric Services : a Journal of the American Psychiatric Association
Matthew A FullerMichael B Durkin
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
J W Hay, J S Schwartz
© 2021 Meta ULC. All rights reserved